SOURCE: Oracle Corporation

Oracle Corporation

December 09, 2009 08:00 ET

Oracle Announces New Release of Oracle® Remote Data Capture With Full Support for Complex Clinical Study Designs

Advanced Electronic Data Capture Application Helps Life Sciences Organizations Bring New Products to Market Faster, More Cost Effectively

REDWOOD SHORES, CA--(Marketwire - December 9, 2009) - Oracle (NASDAQ: ORCL)

News Facts

  • As part of its ongoing commitment to accelerate insights for better health, Oracle today announced Oracle® Remote Data Capture 4.6, the newest release of its next-generation electronic data capture (EDC) application.
  • Designed for speed and safety, Oracle Remote Data Capture helps clinical trial sponsors and contract research organizations (CROs) launch and conduct global clinical trials more efficiently and effectively.
  • Widely used in global, multi-site clinical trials, Oracle Remote Data Capture empowers onsite personnel with unsurpassed functionality, leading to better data quality and reduced time to database lock.
  • The new release features significant enhancements that enable Oracle to fully support increasing demands for complex study design scenarios, including oncology trials.
  • Oracle Remote Data Capture 4.6 enables life sciences organizations to dynamically drive patient visits and assessment schedules based on a patient's data and clinical outcomes, significantly increasing the efficiency and quality of the clinical trial.
  • Usability features such as flexible branching to support complex trial design, the ability to restrict access by role and enhanced assignment of patients to study books have been incorporated into the new release to help streamline patient management throughout the entire life of the study.
  • Oracle Remote Data Capture 4.6 also includes key scalability improvements, which can significantly extend and optimize usage thereby improve IT staff productivity.
  • New functionality and enhancements in Oracle Remote Data Capture 4.6 were developed in collaboration with strategic customer advisors.
  • Oracle Remote Data Capture is integrated with Oracle Clinical, the industry's leading clinical data management system, and is an integral component of Oracle's comprehensive suite of health sciences clinical development and safety applications.

Oracle Remote Data Capture 4.6 Offers Significant Benefits to Life Sciences Organizations and CROs of All Sizes

  • Faster time to market for new products -- enhanced support for complex clinical trials to dramatically improve the timeliness and quality of clinical trial information to enable faster study decisions and more timely feedback to clinical and site personnel
  • Enhanced clinical staff and site productivity -- flexible study support for complex clinical trials results in a significant reduction in time to set up and maintain trials. Intelligent guidance through patient treatment path enables site personnel to quickly identify and respond to data for each patient
  • Improved clinical IT effectiveness -- new functionality significantly reduces IT burden required to support complex trials

Supporting Quote

  • "R&D efficiency, clinical effectiveness and time to market continue to be the greatest challenges facing life sciences organizations today," said Neil de Crescenzo, Senior Vice President and General Manager, Oracle Health Sciences. "Oracle Remote Data Capture 4.6 provides strong evidence of our unwavering commitment to helping clinical trial sponsors and CROs accelerate insights for better health, and will enable our customers to complete clinical trials significantly faster and much more cost effectively than ever before."

Supporting Resources

About Oracle
Oracle (NASDAQ: ORCL) is the world's largest business software company. For more information about Oracle, please visit our Web site at

Oracle is a registered trademark of Oracle Corporation and/or its affiliates. Other names may be trademarks of their respective owners.

Contact Information